Trade Artivion Inc - AORT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.30 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 28.81 |
| Open | 28.89 |
| 1-Year Change | 54.82% |
| Day's Range | 27.95 - 28.89 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 28.07 | -0.49 | -1.72% | 28.56 | 28.95 | 27.92 |
| Feb 20, 2025 | 28.81 | 0.03 | 0.10% | 28.78 | 28.87 | 28.02 |
| Feb 19, 2025 | 29.21 | 0.01 | 0.03% | 29.20 | 29.55 | 28.37 |
| Feb 18, 2025 | 29.73 | 0.21 | 0.71% | 29.52 | 30.07 | 29.42 |
| Feb 14, 2025 | 29.90 | -0.23 | -0.76% | 30.13 | 30.28 | 29.82 |
| Feb 13, 2025 | 29.97 | 0.30 | 1.01% | 29.67 | 30.13 | 29.36 |
| Feb 12, 2025 | 29.67 | -0.28 | -0.93% | 29.95 | 30.10 | 28.93 |
| Feb 11, 2025 | 30.27 | 0.16 | 0.53% | 30.11 | 30.71 | 29.80 |
| Feb 10, 2025 | 30.45 | -0.13 | -0.43% | 30.58 | 30.65 | 30.17 |
| Feb 7, 2025 | 30.41 | -0.69 | -2.22% | 31.10 | 31.29 | 30.09 |
| Feb 6, 2025 | 31.07 | -0.68 | -2.14% | 31.75 | 31.79 | 30.96 |
| Feb 5, 2025 | 31.58 | 0.74 | 2.40% | 30.84 | 31.95 | 30.50 |
| Feb 4, 2025 | 30.89 | 0.47 | 1.55% | 30.42 | 30.89 | 30.05 |
| Feb 3, 2025 | 30.42 | 0.29 | 0.96% | 30.13 | 30.86 | 28.85 |
| Jan 31, 2025 | 30.91 | -0.39 | -1.25% | 31.30 | 31.35 | 30.46 |
| Jan 30, 2025 | 31.28 | -0.01 | -0.03% | 31.29 | 32.03 | 31.13 |
| Jan 29, 2025 | 31.14 | 0.56 | 1.83% | 30.58 | 31.47 | 30.30 |
| Jan 28, 2025 | 30.96 | 1.73 | 5.92% | 29.23 | 31.05 | 29.23 |
| Jan 27, 2025 | 30.45 | 0.69 | 2.32% | 29.76 | 31.09 | 29.76 |
| Jan 24, 2025 | 30.51 | 0.24 | 0.79% | 30.27 | 30.76 | 29.96 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Artivion Inc Company profile
About Artivion Inc
Artivion, Inc. (Artivion), formerly CryoLife, Inc., is a medical device company. The Company is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The Company's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. It offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The Company's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Artivion Inc revenues increased 18% to $298.8M. Net loss applicable to common stockholders decreased 11% to $14.7M. Revenues reflect Medical Devices segment increase of 24% to $221.6M, Preservation services segment increase of 4% to $77.2M, International segment increase of 28% to $147.7M, United States segment increase of 9% to $151.2M.
Equity composition
Common Stock $.01 Par, 03/11, 75M auth., 29,950,000 issd., less 2,053,000 shares in Treas. @ $11.7M. Insiders own 6.85% . IPO 2/93, 1.5M shs @ $10 by Robinson-Humphrey. PO 4/98, 2.75M shs (2.513M by Co.) @ $16.50 by SBC Warburg Dillon Read. 12/00, 3-for-2 split; 7/96, 2-for-1 split. FY'01 Qs are restated.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
1655 Roberts Boulevard N W
KENNESAW
GEORGIA 30144
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com